{"name":"Nerre Therapeutics Ltd.","slug":"nerre-therapeutics-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxOb2FpNnlvQ2NMX0ZSTnZkdGtFUXhFUzhyRXA4SjJQcF9uOHZRaWJDZ1hDUnZ0T0pLWmthYWRmM2NGTVNDZkFOQnZPbFlhY0lNUnJmNkpnYll3eERNOW8wVS1VMFV2QnE5bWMzZDBFcGduUUpqaDBpZGtSNlE1SDVDRTMxNENyMFJud3F0S3pyUi1rMHZhZ1JhUHNtc1VScWZoZkszc0lMYVFOaWhpUk5QMVhtbl92VU9WWlJnR2VwSnp5elhiV1hENHVXV0FpemhUa29jd0JxUGJqWnVFcTZ2dnAxWDQ4LTN4T3pyZ0xIcWtJdFk3dFVqaEp2cng2b0lSOTd0YTVQNGFXMzZteTA0N3VpbDg0U3dDT2J2QVliNGdPUldNa0Zndi1mRzZ3a3h1dHc?oc=5","date":"2026-02-09","type":"trial","source":"GlobeNewswire","summary":"Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline - GlobeNewswire","headline":"Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQUEcxSEtTTExZMzliYlozbklpS0h1UVRkRnJvS2FlYlFzX3Y1ZHluSlM3Vk9XUkhIOVB4akJMUkhhNDFsd1RmRFhwOTlkUURLa3NlNkM3ZVVaQTJRRnYyVXFSeHBtS3ltUjNRT0VseXFtSEJqWG9GS2RoYU1KMmU4QWZBdjZkN01FRUpaVEFJV3VucG1NZXllQ3NwOGdFcXNENjBydg?oc=5","date":"2025-09-19","type":"regulatory","source":"BioWorld News","summary":"CHMP recommends EU approval of Bayer’s Lynkuet for hot flashes - BioWorld News","headline":"CHMP recommends EU approval of Bayer’s Lynkuet for hot flashes","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxPODR6a0JUUjQ2d3pHa2c0M3gtN2ZRMDVGandaRFJha3VIMjg3OEdjWTRZTk1uMlV4Z3ktQUhXZGgxNW9oYmRPQ29NSlpwYklHenlyOElhTnhHTENKZldhZ1JiZ3RWU19CLW5vRUVGWEpneEs4dGY5V1gxRnhHanA2Ni1qQno5SnkyZG40dWxyYWVzVFM4Z2hKaHJqTlg2OEkzTnhMd0hveW5vdEhiRENMVEFxTlVtV1ZwejdjVHhnVlYtR1lhbDVuRzU3YlVETDR3bjhhZm40LWVNcUpKQVdpY2FHZl9JTWQ2VDVRR19KdjFVd1o5RUQzOERDMkZQcEpLWTNwZVJtcjgzR2ppYUJRS01kMnUxOUpLSDlwWFVHT19EaVZDSFhaS2F5cHpNa0MwZjcwVXY1X0dSejgwNUE?oc=5","date":"2025-01-28","type":"trial","source":"GlobeNewswire","summary":"Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust - GlobeNewswire","headline":"Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTFBqb3RqX09XdDk3Qk40SzZxbFZQNldLM2Z3c1BOTHhVWEFTZEVlOWdXajFlcWV5M2NXN3duNWlzNE5kT084dEljcE1LZUtfRnNyWUIzdmlWbm4?oc=5","date":"2024-11-26","type":"pipeline","source":"Market.us","summary":"Antipruritic Market Size, Share | CAGR Of 5.6% - Market.us","headline":"Antipruritic Market Size, Share | CAGR Of 5.6%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxNc1BSX1Vlb2xnUFVQLVpybnV0NldIQjZ1MExoX0RvTnRiMk9SU2xxeHBMVFMtd2EwTGxMTFhLa1Z5SVE1blppZjl4akQ2TlM5TVJmUmhJZV9kNmNpb09aVktqTE5vNTYxTFU5ZFpfVEQwc1N3eGN1YmVfVzVNWndhdjV4Ql82OXkwcnM2Qk1oWnVCdnIxV19uT1NYYzJ2dmhuUUd4TVljV1dDc0tSUlpqY0lyQk5oS2QzbFhyTWtwYXdITlJsRlJ1WFVCUmgyYU5xM1NFRE1nbGhFV1QtdzZVaDk0WlhiY2pUaFJZdmlHUDdSZ2RVNlVxeDhxYjlsZmxVNWNoaVdLaGpqdUk?oc=5","date":"2024-11-20","type":"pipeline","source":"prnewswire.com","summary":"Chronic Refractory Cough Market Still Unexplored, with Pharma Companies Eyeing First-Mover Advantage in the US | DelveInsight - prnewswire.com","headline":"Chronic Refractory Cough Market Still Unexplored, with Pharma Companies Eyeing First-Mover Advantage in the US | DelveIn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPZ3JtZ1NSd2lzV3NKcVdzU3NMYy1hZDh3anB3VmgxRS04aEpBRlQwNjRDMF94QkoyZ3dBVnpURWI5aWlXSVZCMGhseDA4akhkeHNCaENHTkk0M3pqc2FlMlBzazFXVDhiLWdFMGk4dzJrUWgxYkNONC12UDdSUzRBZ0RyWkRET0k2YTJSTjVTTUwyY3A3TEp5dzNUX052c1YxRHVBSXd0aWpfUmlOQTNHY2J5dThGbjBRS01zZWpxdzUwelVhWmN0WWdyWjk2dGVBeGlUc2Ffb1h3eHlaelh5bWEtRHNVdktSUjNldU9n?oc=5","date":"2024-09-26","type":"pipeline","source":"prnewswire.com","summary":"Global Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6% by 2030 | DelveInsight - prnewswire.com","headline":"Global Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxQRE0tVHFDTkFjR0pnOEVHY2RxaEFtc3Nna2piVk9FZEg3VjhhOTJSb2FvWGpRdFhJRlFvNVdOV3FfYkJTNGVaSEVGbVpPWjh3REFta3NxM2tSckNkX3dBNVFNWTNUeHdtcVRtdDc0bTMzMVNlTHF6MnNDTUFDcWMxV3dzYmNJbWxUbDJSeGhFdC1wMnU5bG9hZ1h5MDRHM0tWS09WM0xZWkkzUXpOZlNEc25QVmlRNndvZExKZjV0VWFBVlNPTXM1SUJ3em11VzByRUhndk1wRE1ILWVMOUxjXzBXYw?oc=5","date":"2024-09-09","type":"pipeline","source":"prnewswire.com","summary":"Idiopathic Pulmonary Fibrosis Treatment Drug Market to Increase 2 Folds by 2034 | DelveInsight - prnewswire.com","headline":"Idiopathic Pulmonary Fibrosis Treatment Drug Market to Increase 2 Folds by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxNVGhpZEFiUzhvRU5fTEFRVm51dXgyT1E2WDVDZ1UxYTJQdi1UV0w4eVhwSGN4Z2wyUk1nUmdSbGZXcGpzb2RzNTNwNWpTTHZiSUJ2ZFlyMUFxMzFXcDNEZTNnd1k0ZkRTVW11UW01SEJval8wc3RaQmJ4UGJYeFAtOXBQcmxSMWYxX3BEejViZEQ0NU5sdldoNWlCVnRpWEVUZVZ5Mm5ScXdtbGVXR2JmSVhia091d1QyRDZ4UXE2cHlNMXpJaUtKX3FYZDB5ZkZfT3k2dFREMzBRdnlWTnNmOFItYy16VjFVMUNhYUFvMlZpbnBzeUdPWHN2R1YxbEwzU1JlaDhKSldqTWs?oc=5","date":"2024-04-03","type":"pipeline","source":"prnewswire.com","summary":"Cough in Idiopathic Pulmonary Fibrosis Therapeutics Market to Exhibit Immense Growth at a CAGR of 4.9% by 2034 | DelveInsight - prnewswire.com","headline":"Cough in Idiopathic Pulmonary Fibrosis Therapeutics Market to Exhibit Immense Growth at a CAGR of 4.9% by 2034 | DelveIn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOUVFZblNLa1VORlBwc3dEZk1JbU9ySVJDdEdIZEdOXzVoN1hsU0cwRFltbVQ2TGczdjJUZ210dFNzTVJnTGxtSWxRcTNwbUZQOHNXZVYySTNTc3lzM0NnYmYzREhuQXdvQTI2ZjFEYmNrS1NPXzdNRzc3ajNUWWhvZ1kxVEZrazZJQTkwdS1B?oc=5","date":"2023-09-06","type":"pipeline","source":"Yahoo Finance","summary":"Chronic Refractory Cough Market to Observe Stupendous Growth by 2032, Assesses DelveInsight | Key Players to Watch Out - Merck, Kyorin, NeRRe, Bellus Health, GSK, Axalbion, Aldeyra, Genentech - Yahoo ","headline":"Chronic Refractory Cough Market to Observe Stupendous Growth by 2032, Assesses DelveInsight | Key Players to Watch Out -","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOZUdPVHRvRlY0UlUwUHlXMGtqN2ZfVThFMEgzbUpUU2RpWlZKaUhyWVpybEZrYlE2ZUlncUh3TXlNcXd6dkotbVhHTXQ5Smlaa0JGSHlCRkFlZTFGM3hhNjNzamFtY2xYN1M3ekFDVUp0RS0wZi1IY2d4SUx0ZmlrRzRGcThTYWlzVnRoajBQSkZ4dllyeTRSeFNDRG41dVlCQkZKVG9ndEhRSWpQM2dmbUM5WjE?oc=5","date":"2020-08-11","type":"deal","source":"businesswire.com","summary":"Bayer to Acquire UK-Based Biotech KaNDy Therapeutics Ltd. - businesswire.com","headline":"Bayer to Acquire UK-Based Biotech KaNDy Therapeutics Ltd.","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}